nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SCNN1D—nose—brain cancer	0.0639	0.149	CbGeAlD
Amiloride—SCNN1A—nose—brain cancer	0.0499	0.116	CbGeAlD
Amiloride—PLAU—Dissolution of Fibrin Clot—S100A10—brain cancer	0.0327	0.113	CbGpPWpGaD
Amiloride—ASIC2—ganglion—brain cancer	0.0281	0.0652	CbGeAlD
Amiloride—ASIC1—ganglion—brain cancer	0.0177	0.0413	CbGeAlD
Amiloride—PLAU—endothelium—brain cancer	0.0139	0.0323	CbGeAlD
Amiloride—SLC9A1—RhoA signaling pathway—PPP1R12A—brain cancer	0.0134	0.0464	CbGpPWpGaD
Amiloride—PLAU—blood vessel—brain cancer	0.0128	0.0298	CbGeAlD
Amiloride—PLAU—E2F transcription factor network—HIC1—brain cancer	0.0119	0.041	CbGpPWpGaD
Amiloride—ASIC2—telencephalon—brain cancer	0.0108	0.0252	CbGeAlD
Amiloride—PLAU—Osteopontin Signaling—SPP1—brain cancer	0.00899	0.0311	CbGpPWpGaD
Amiloride—ASIC2—pituitary gland—brain cancer	0.00881	0.0205	CbGeAlD
Amiloride—ASIC2—medulla oblongata—brain cancer	0.0085	0.0198	CbGeAlD
Amiloride—SLC9A1—Osteoclast Signaling—SPP1—brain cancer	0.00844	0.0292	CbGpPWpGaD
Amiloride—SCNN1D—telencephalon—brain cancer	0.00697	0.0162	CbGeAlD
Amiloride—ASIC1—telencephalon—brain cancer	0.00685	0.0159	CbGeAlD
Amiloride—ASIC2—Stimuli-sensing channels—TRPC6—brain cancer	0.00682	0.0236	CbGpPWpGaD
Amiloride—ASIC2—head—brain cancer	0.00674	0.0157	CbGeAlD
Amiloride—PLAU—Beta1 integrin cell surface interactions—TGM2—brain cancer	0.00662	0.0229	CbGpPWpGaD
Amiloride—SLC9A1—telencephalon—brain cancer	0.00656	0.0152	CbGeAlD
Amiloride—ASIC2—central nervous system—brain cancer	0.00615	0.0143	CbGeAlD
Amiloride—ASIC2—cerebellum—brain cancer	0.00601	0.014	CbGeAlD
Amiloride—SCNN1D—gonad—brain cancer	0.00582	0.0135	CbGeAlD
Amiloride—Visual disturbance—Lomustine—brain cancer	0.00581	0.0207	CcSEcCtD
Amiloride—SCNN1G—pituitary gland—brain cancer	0.00568	0.0132	CbGeAlD
Amiloride—PLAU—Osteopontin Signaling—RELA—brain cancer	0.00561	0.0194	CbGpPWpGaD
Amiloride—Digestion impaired—Hydroxyurea—brain cancer	0.00557	0.0198	CcSEcCtD
Amiloride—SCNN1A—telencephalon—brain cancer	0.00544	0.0127	CbGeAlD
Amiloride—SLC22A1—ganglion—brain cancer	0.00538	0.0125	CbGeAlD
Amiloride—ASIC1—medulla oblongata—brain cancer	0.00538	0.0125	CbGeAlD
Amiloride—SCNN1D—Stimuli-sensing channels—TRPC6—brain cancer	0.00517	0.0179	CbGpPWpGaD
Amiloride—SCNN1B—Stimuli-sensing channels—TRPC6—brain cancer	0.00517	0.0179	CbGpPWpGaD
Amiloride—SCNN1A—Stimuli-sensing channels—TRPC6—brain cancer	0.00517	0.0179	CbGpPWpGaD
Amiloride—ASIC1—Stimuli-sensing channels—TRPC6—brain cancer	0.00517	0.0179	CbGpPWpGaD
Amiloride—SCNN1G—Stimuli-sensing channels—TRPC6—brain cancer	0.00517	0.0179	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.00515	0.0178	CbGpPWpGaD
Amiloride—PLAU—pituitary gland—brain cancer	0.00506	0.0118	CbGeAlD
Amiloride—SCNN1B—gonad—brain cancer	0.00492	0.0114	CbGeAlD
Amiloride—ASIC1—midbrain—brain cancer	0.00492	0.0114	CbGeAlD
Amiloride—ASIC2—brain—brain cancer	0.00488	0.0114	CbGeAlD
Amiloride—ASIC1—spinal cord—brain cancer	0.0048	0.0112	CbGeAlD
Amiloride—SLC9A1—Endothelins—TRPC6—brain cancer	0.00473	0.0164	CbGpPWpGaD
Amiloride—SLC9A1—midbrain—brain cancer	0.00471	0.0109	CbGeAlD
Amiloride—Encephalopathy—Carmustine—brain cancer	0.00469	0.0167	CcSEcCtD
Amiloride—PLAU—Osteopontin-mediated events—SPP1—brain cancer	0.00448	0.0155	CbGpPWpGaD
Amiloride—ASIC2—Ion channel transport—TRPC6—brain cancer	0.00445	0.0154	CbGpPWpGaD
Amiloride—SCNN1A—pituitary gland—brain cancer	0.00443	0.0103	CbGeAlD
Amiloride—SCNN1D—endocrine gland—brain cancer	0.0044	0.0102	CbGeAlD
Amiloride—Coma—Procarbazine—brain cancer	0.0044	0.0157	CcSEcCtD
Amiloride—Digestion impaired—Temozolomide—brain cancer	0.00435	0.0155	CcSEcCtD
Amiloride—SCNN1D—head—brain cancer	0.00434	0.0101	CbGeAlD
Amiloride—AOC1—endocrine gland—brain cancer	0.00432	0.01	CbGeAlD
Amiloride—ASIC1—endocrine gland—brain cancer	0.00432	0.01	CbGeAlD
Amiloride—Gynaecomastia—Procarbazine—brain cancer	0.00431	0.0153	CcSEcCtD
Amiloride—ASIC1—head—brain cancer	0.00426	0.00991	CbGeAlD
Amiloride—PLAU—Endochondral Ossification—PTCH1—brain cancer	0.00414	0.0143	CbGpPWpGaD
Amiloride—SLC9A1—endocrine gland—brain cancer	0.00414	0.00962	CbGeAlD
Amiloride—SLC9A1—head—brain cancer	0.00408	0.00949	CbGeAlD
Amiloride—Hyperuricaemia—Hydroxyurea—brain cancer	0.00402	0.0143	CcSEcCtD
Amiloride—Hepatic function abnormal—Procarbazine—brain cancer	0.004	0.0142	CcSEcCtD
Amiloride—SCNN1D—central nervous system—brain cancer	0.00396	0.00922	CbGeAlD
Amiloride—PLAU—endocrine gland—brain cancer	0.00392	0.00912	CbGeAlD
Amiloride—ASIC1—central nervous system—brain cancer	0.00389	0.00905	CbGeAlD
Amiloride—SCNN1G—cerebellum—brain cancer	0.00387	0.00901	CbGeAlD
Amiloride—SCNN1D—cerebellum—brain cancer	0.00387	0.00901	CbGeAlD
Amiloride—PLAU—head—brain cancer	0.00387	0.009	CbGeAlD
Amiloride—Haemoglobin—Lomustine—brain cancer	0.00383	0.0136	CcSEcCtD
Amiloride—Haemorrhage—Lomustine—brain cancer	0.00381	0.0136	CcSEcCtD
Amiloride—ASIC1—cerebellum—brain cancer	0.0038	0.00884	CbGeAlD
Amiloride—Blood uric acid increased—Hydroxyurea—brain cancer	0.00379	0.0135	CcSEcCtD
Amiloride—SLC9A1—central nervous system—brain cancer	0.00373	0.00866	CbGeAlD
Amiloride—SCNN1B—endocrine gland—brain cancer	0.00372	0.00864	CbGeAlD
Amiloride—SCNN1B—head—brain cancer	0.00367	0.00853	CbGeAlD
Amiloride—Visual impairment—Lomustine—brain cancer	0.00367	0.0131	CcSEcCtD
Amiloride—SLC9A1—cerebellum—brain cancer	0.00364	0.00847	CbGeAlD
Amiloride—PLAU—central nervous system—brain cancer	0.00353	0.00821	CbGeAlD
Amiloride—PLAU—Beta3 integrin cell surface interactions—SPP1—brain cancer	0.00345	0.0119	CbGpPWpGaD
Amiloride—SCNN1A—endocrine gland—brain cancer	0.00343	0.00798	CbGeAlD
Amiloride—SCNN1A—head—brain cancer	0.00339	0.00788	CbGeAlD
Amiloride—SCNN1A—Ion channel transport—TRPC6—brain cancer	0.00337	0.0117	CbGpPWpGaD
Amiloride—SCNN1D—Ion channel transport—TRPC6—brain cancer	0.00337	0.0117	CbGpPWpGaD
Amiloride—ASIC1—Ion channel transport—TRPC6—brain cancer	0.00337	0.0117	CbGpPWpGaD
Amiloride—SCNN1B—Ion channel transport—TRPC6—brain cancer	0.00337	0.0117	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—TRPC6—brain cancer	0.00337	0.0117	CbGpPWpGaD
Amiloride—Alopecia—Lomustine—brain cancer	0.00336	0.012	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00335	0.0116	CbGpPWpGaD
Amiloride—SCNN1B—central nervous system—brain cancer	0.00335	0.00779	CbGeAlD
Amiloride—SCNN1D—brain—brain cancer	0.00315	0.00732	CbGeAlD
Amiloride—ASIC1—brain—brain cancer	0.00309	0.00718	CbGeAlD
Amiloride—Neck pain—Carmustine—brain cancer	0.00305	0.0109	CcSEcCtD
Amiloride—SLC9A1—brain—brain cancer	0.00296	0.00688	CbGeAlD
Amiloride—Angina pectoris—Procarbazine—brain cancer	0.00294	0.0105	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—HES1—brain cancer	0.0029	0.01	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—SPP1—brain cancer	0.00288	0.00995	CbGpPWpGaD
Amiloride—PLAU—brain—brain cancer	0.0028	0.00652	CbGeAlD
Amiloride—PLAU—Osteopontin-mediated events—RELA—brain cancer	0.0028	0.00968	CbGpPWpGaD
Amiloride—Pollakiuria—Procarbazine—brain cancer	0.00279	0.00993	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—PDGFRA—brain cancer	0.00276	0.00955	CbGpPWpGaD
Amiloride—Coma—Carmustine—brain cancer	0.00275	0.0098	CcSEcCtD
Amiloride—Aplastic anaemia—Temozolomide—brain cancer	0.00273	0.00973	CcSEcCtD
Amiloride—Gynaecomastia—Carmustine—brain cancer	0.00269	0.0096	CcSEcCtD
Amiloride—SCNN1B—brain—brain cancer	0.00266	0.00618	CbGeAlD
Amiloride—Pain—Carboplatin—brain cancer	0.00264	0.00942	CcSEcCtD
Amiloride—Jaundice—Procarbazine—brain cancer	0.00262	0.00935	CcSEcCtD
Amiloride—Anorexia—Lomustine—brain cancer	0.00258	0.00918	CcSEcCtD
Amiloride—SCNN1D—Transmembrane transport of small molecules—S100A10—brain cancer	0.00254	0.00879	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—S100A10—brain cancer	0.00254	0.00879	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—S100A10—brain cancer	0.00254	0.00879	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—S100A10—brain cancer	0.00254	0.00879	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00254	0.00879	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—SIRT1—brain cancer	0.00254	0.00877	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—brain cancer	0.00252	0.00873	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—SPP1—brain cancer	0.00251	0.00869	CbGpPWpGaD
Amiloride—Hyperuricaemia—Etoposide—brain cancer	0.00251	0.00894	CcSEcCtD
Amiloride—PLAU—E2F transcription factor network—CCNE1—brain cancer	0.0025	0.00866	CbGpPWpGaD
Amiloride—SCNN1A—brain—brain cancer	0.00246	0.00571	CbGeAlD
Amiloride—PLAU—Beta1 integrin cell surface interactions—SPP1—brain cancer	0.00245	0.00848	CbGpPWpGaD
Amiloride—Haemoglobin—Procarbazine—brain cancer	0.00243	0.00865	CcSEcCtD
Amiloride—Haemorrhage—Procarbazine—brain cancer	0.00242	0.00861	CcSEcCtD
Amiloride—Blood uric acid increased—Etoposide—brain cancer	0.00237	0.00844	CcSEcCtD
Amiloride—Decreased appetite—Lomustine—brain cancer	0.00235	0.00837	CcSEcCtD
Amiloride—Nasal congestion—Temozolomide—brain cancer	0.00232	0.00826	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—CDK4—brain cancer	0.00227	0.00787	CbGpPWpGaD
Amiloride—Thirst—Temozolomide—brain cancer	0.00222	0.0079	CcSEcCtD
Amiloride—Hyponatraemia—Carmustine—brain cancer	0.00219	0.00782	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00219	0.00778	CcSEcCtD
Amiloride—Neutropenia—Hydroxyurea—brain cancer	0.00219	0.00778	CcSEcCtD
Amiloride—Dysuria—Hydroxyurea—brain cancer	0.00219	0.00778	CcSEcCtD
Amiloride—Alopecia—Procarbazine—brain cancer	0.00214	0.00761	CcSEcCtD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—brain cancer	0.00213	0.00738	CbGpPWpGaD
Amiloride—SLC22A1—telencephalon—brain cancer	0.00208	0.00483	CbGeAlD
Amiloride—Tension—Procarbazine—brain cancer	0.00206	0.00735	CcSEcCtD
Amiloride—Nervousness—Procarbazine—brain cancer	0.00204	0.00728	CcSEcCtD
Amiloride—Tremor—Procarbazine—brain cancer	0.00197	0.00702	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway—APC—brain cancer	0.00193	0.00669	CbGpPWpGaD
Amiloride—Muscular weakness—Carmustine—brain cancer	0.00193	0.00687	CcSEcCtD
Amiloride—Haemoglobin—Hydroxyurea—brain cancer	0.00188	0.0067	CcSEcCtD
Amiloride—Haemorrhage—Hydroxyurea—brain cancer	0.00187	0.00666	CcSEcCtD
Amiloride—Muscular weakness—Temozolomide—brain cancer	0.00186	0.00664	CcSEcCtD
Amiloride—Abdominal distension—Temozolomide—brain cancer	0.00184	0.00655	CcSEcCtD
Amiloride—Cough—Procarbazine—brain cancer	0.00184	0.00654	CcSEcCtD
Amiloride—PLAU—Hemostasis—MPL—brain cancer	0.00182	0.0063	CbGpPWpGaD
Amiloride—Arthralgia—Procarbazine—brain cancer	0.00179	0.00638	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—VAV1—brain cancer	0.00178	0.00616	CbGpPWpGaD
Amiloride—SLC22A4—pituitary gland—brain cancer	0.00178	0.00413	CbGeAlD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—SOD2—brain cancer	0.00177	0.00613	CbGpPWpGaD
Amiloride—Neutropenia—Carmustine—brain cancer	0.00177	0.00629	CcSEcCtD
Amiloride—PLAU—Hemostasis—S100A10—brain cancer	0.00175	0.00604	CbGpPWpGaD
Amiloride—Confusional state—Procarbazine—brain cancer	0.00173	0.00617	CcSEcCtD
Amiloride—Vomiting—Lomustine—brain cancer	0.00172	0.00612	CcSEcCtD
Amiloride—Neutropenia—Temozolomide—brain cancer	0.00171	0.00608	CcSEcCtD
Amiloride—Dysuria—Temozolomide—brain cancer	0.00171	0.00608	CcSEcCtD
Amiloride—Shock—Procarbazine—brain cancer	0.00169	0.00602	CcSEcCtD
Amiloride—Pollakiuria—Temozolomide—brain cancer	0.00169	0.00601	CcSEcCtD
Amiloride—Erectile dysfunction—Temozolomide—brain cancer	0.00168	0.00599	CcSEcCtD
Amiloride—Depression—Carmustine—brain cancer	0.00168	0.00598	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00168	0.0058	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—PCNA—brain cancer	0.00166	0.00574	CbGpPWpGaD
Amiloride—Alopecia—Hydroxyurea—brain cancer	0.00165	0.00589	CcSEcCtD
Amiloride—PLAU—Beta3 integrin cell surface interactions—VEGFA—brain cancer	0.00165	0.0057	CbGpPWpGaD
Amiloride—Anorexia—Procarbazine—brain cancer	0.00164	0.00583	CcSEcCtD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.00163	0.00563	CbGpPWpGaD
Amiloride—Depression—Temozolomide—brain cancer	0.00162	0.00578	CcSEcCtD
Amiloride—Nausea—Lomustine—brain cancer	0.00161	0.00572	CcSEcCtD
Amiloride—SLC9A1—Carbohydrate metabolism—ENO2—brain cancer	0.00158	0.00548	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00156	0.00557	CcSEcCtD
Amiloride—Insomnia—Procarbazine—brain cancer	0.00155	0.00553	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00155	0.00536	CbGpPWpGaD
Amiloride—Paraesthesia—Procarbazine—brain cancer	0.00154	0.00549	CcSEcCtD
Amiloride—SLC22A4—spinal cord—brain cancer	0.00153	0.00355	CbGeAlD
Amiloride—Somnolence—Procarbazine—brain cancer	0.00153	0.00544	CcSEcCtD
Amiloride—Cramp muscle—Etoposide—brain cancer	0.00152	0.00542	CcSEcCtD
Amiloride—Haemoglobin—Carmustine—brain cancer	0.00152	0.00541	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—CDKN2A—brain cancer	0.00152	0.00524	CbGpPWpGaD
Amiloride—Haemorrhage—Carmustine—brain cancer	0.00151	0.00539	CcSEcCtD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—brain cancer	0.00151	0.00523	CbGpPWpGaD
Amiloride—Decreased appetite—Procarbazine—brain cancer	0.00149	0.00532	CcSEcCtD
Amiloride—Fatigue—Procarbazine—brain cancer	0.00148	0.00527	CcSEcCtD
Amiloride—Haemoglobin—Temozolomide—brain cancer	0.00147	0.00523	CcSEcCtD
Amiloride—Constipation—Procarbazine—brain cancer	0.00147	0.00523	CcSEcCtD
Amiloride—Pain—Procarbazine—brain cancer	0.00147	0.00523	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—CCND1—brain cancer	0.00147	0.00508	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—CDKN2A—brain cancer	0.00147	0.00507	CbGpPWpGaD
Amiloride—Haemorrhage—Temozolomide—brain cancer	0.00146	0.0052	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	0.00146	0.00505	CbGpPWpGaD
Amiloride—Visual impairment—Carmustine—brain cancer	0.00146	0.00519	CcSEcCtD
Amiloride—Feeling abnormal—Procarbazine—brain cancer	0.00142	0.00504	CcSEcCtD
Amiloride—Visual impairment—Temozolomide—brain cancer	0.00141	0.00502	CcSEcCtD
Amiloride—Gastrointestinal pain—Procarbazine—brain cancer	0.0014	0.005	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—APC—brain cancer	0.00138	0.00478	CbGpPWpGaD
Amiloride—Neutropenia—Etoposide—brain cancer	0.00137	0.00487	CcSEcCtD
Amiloride—Tinnitus—Temozolomide—brain cancer	0.00136	0.00485	CcSEcCtD
Amiloride—PLAU—FGF signaling pathway—STAT3—brain cancer	0.00136	0.00471	CbGpPWpGaD
Amiloride—Abdominal pain—Procarbazine—brain cancer	0.00136	0.00483	CcSEcCtD
Amiloride—Alopecia—Carmustine—brain cancer	0.00134	0.00476	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway—CCND1—brain cancer	0.00133	0.00459	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL2—brain cancer	0.00131	0.00454	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—CTNNB1—brain cancer	0.00131	0.00454	CbGpPWpGaD
Amiloride—SLC22A1—endocrine gland—brain cancer	0.00131	0.00305	CbGeAlD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—APC—brain cancer	0.00131	0.00453	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CG—brain cancer	0.00131	0.00453	CbGpPWpGaD
Amiloride—SLC22A1—head—brain cancer	0.00129	0.00301	CbGeAlD
Amiloride—Alopecia—Temozolomide—brain cancer	0.00129	0.0046	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—CCND1—brain cancer	0.00128	0.00443	CbGpPWpGaD
Amiloride—Back pain—Carmustine—brain cancer	0.00127	0.00453	CcSEcCtD
Amiloride—Jaundice—Etoposide—brain cancer	0.00127	0.00452	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—CTNNB1—brain cancer	0.00127	0.00439	CbGpPWpGaD
Amiloride—Anorexia—Hydroxyurea—brain cancer	0.00127	0.00451	CcSEcCtD
Amiloride—Tremor—Carmustine—brain cancer	0.00123	0.00439	CcSEcCtD
Amiloride—Asthenia—Procarbazine—brain cancer	0.00123	0.00439	CcSEcCtD
Amiloride—Back pain—Temozolomide—brain cancer	0.00123	0.00438	CcSEcCtD
Amiloride—PLAU—Hemostasis—BSG—brain cancer	0.00123	0.00426	CbGpPWpGaD
Amiloride—Pruritus—Procarbazine—brain cancer	0.00122	0.00433	CcSEcCtD
Amiloride—SLC22A4—cerebellum—brain cancer	0.00121	0.00282	CbGeAlD
Amiloride—PLAU—Endochondral Ossification—VEGFA—brain cancer	0.0012	0.00415	CbGpPWpGaD
Amiloride—Tremor—Temozolomide—brain cancer	0.00119	0.00424	CcSEcCtD
Amiloride—Dyspnoea—Hydroxyurea—brain cancer	0.00118	0.00422	CcSEcCtD
Amiloride—Somnolence—Hydroxyurea—brain cancer	0.00118	0.00421	CcSEcCtD
Amiloride—SLC22A1—central nervous system—brain cancer	0.00118	0.00274	CbGeAlD
Amiloride—Diarrhoea—Procarbazine—brain cancer	0.00118	0.00418	CcSEcCtD
Amiloride—SCNN1A—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00117	0.00406	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00117	0.00406	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00117	0.00406	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00117	0.00406	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00117	0.00406	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—VEGFA—brain cancer	0.00117	0.00405	CbGpPWpGaD
Amiloride—Dyspepsia—Hydroxyurea—brain cancer	0.00117	0.00417	CcSEcCtD
Amiloride—Decreased appetite—Hydroxyurea—brain cancer	0.00116	0.00411	CcSEcCtD
Amiloride—SLC9A1—Disease—DTX2—brain cancer	0.00115	0.00398	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00115	0.00409	CcSEcCtD
Amiloride—Fatigue—Hydroxyurea—brain cancer	0.00115	0.00408	CcSEcCtD
Amiloride—Vertigo—Temozolomide—brain cancer	0.00114	0.00407	CcSEcCtD
Amiloride—Constipation—Hydroxyurea—brain cancer	0.00114	0.00405	CcSEcCtD
Amiloride—Pain—Hydroxyurea—brain cancer	0.00114	0.00405	CcSEcCtD
Amiloride—Dizziness—Procarbazine—brain cancer	0.00114	0.00404	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—APC—brain cancer	0.00113	0.00391	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	0.00113	0.00391	CbGpPWpGaD
Amiloride—Palpitations—Temozolomide—brain cancer	0.00112	0.004	CcSEcCtD
Amiloride—Chest pain—Carmustine—brain cancer	0.00112	0.00399	CcSEcCtD
Amiloride—Cough—Temozolomide—brain cancer	0.00111	0.00395	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN2A—brain cancer	0.0011	0.00379	CbGpPWpGaD
Amiloride—Feeling abnormal—Hydroxyurea—brain cancer	0.0011	0.0039	CcSEcCtD
Amiloride—Vomiting—Procarbazine—brain cancer	0.00109	0.00389	CcSEcCtD
Amiloride—Confusional state—Carmustine—brain cancer	0.00108	0.00386	CcSEcCtD
Amiloride—Arthralgia—Temozolomide—brain cancer	0.00108	0.00386	CcSEcCtD
Amiloride—Rash—Procarbazine—brain cancer	0.00108	0.00386	CcSEcCtD
Amiloride—Dermatitis—Procarbazine—brain cancer	0.00108	0.00385	CcSEcCtD
Amiloride—Headache—Procarbazine—brain cancer	0.00108	0.00383	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway—MYC—brain cancer	0.00106	0.00368	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN2A—brain cancer	0.00106	0.00368	CbGpPWpGaD
Amiloride—Confusional state—Temozolomide—brain cancer	0.00105	0.00373	CcSEcCtD
Amiloride—Alopecia—Etoposide—brain cancer	0.00103	0.00368	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—MYC—brain cancer	0.00103	0.00355	CbGpPWpGaD
Amiloride—Anorexia—Carmustine—brain cancer	0.00102	0.00365	CcSEcCtD
Amiloride—Nausea—Procarbazine—brain cancer	0.00102	0.00363	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—ERBB2—brain cancer	0.00102	0.00352	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—MYC—brain cancer	0.000993	0.00344	CbGpPWpGaD
Amiloride—Anorexia—Temozolomide—brain cancer	0.00099	0.00352	CcSEcCtD
Amiloride—Back pain—Etoposide—brain cancer	0.000985	0.00351	CcSEcCtD
Amiloride—SLC22A4—brain—brain cancer	0.000984	0.00229	CbGeAlD
Amiloride—Musculoskeletal discomfort—Carmustine—brain cancer	0.000979	0.00349	CcSEcCtD
Amiloride—Muscle spasms—Etoposide—brain cancer	0.000979	0.00349	CcSEcCtD
Amiloride—Insomnia—Carmustine—brain cancer	0.000972	0.00346	CcSEcCtD
Amiloride—Paraesthesia—Carmustine—brain cancer	0.000965	0.00344	CcSEcCtD
Amiloride—Dyspnoea—Carmustine—brain cancer	0.000958	0.00341	CcSEcCtD
Amiloride—Somnolence—Carmustine—brain cancer	0.000955	0.0034	CcSEcCtD
Amiloride—Asthenia—Hydroxyurea—brain cancer	0.000954	0.0034	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CCND1—brain cancer	0.000948	0.00328	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000946	0.00337	CcSEcCtD
Amiloride—Insomnia—Temozolomide—brain cancer	0.000939	0.00334	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CTNNB1—brain cancer	0.000938	0.00325	CbGpPWpGaD
Amiloride—SLC22A1—brain—brain cancer	0.000937	0.00218	CbGeAlD
Amiloride—Decreased appetite—Carmustine—brain cancer	0.000934	0.00333	CcSEcCtD
Amiloride—Paraesthesia—Temozolomide—brain cancer	0.000932	0.00332	CcSEcCtD
Amiloride—Gastrointestinal disorder—Carmustine—brain cancer	0.000928	0.0033	CcSEcCtD
Amiloride—Dyspnoea—Temozolomide—brain cancer	0.000926	0.0033	CcSEcCtD
Amiloride—Somnolence—Temozolomide—brain cancer	0.000923	0.00329	CcSEcCtD
Amiloride—Constipation—Carmustine—brain cancer	0.000919	0.00327	CcSEcCtD
Amiloride—Pain—Carmustine—brain cancer	0.000919	0.00327	CcSEcCtD
Amiloride—Vertigo—Etoposide—brain cancer	0.000915	0.00326	CcSEcCtD
Amiloride—Dyspepsia—Temozolomide—brain cancer	0.000914	0.00325	CcSEcCtD
Amiloride—Diarrhoea—Hydroxyurea—brain cancer	0.000909	0.00324	CcSEcCtD
Amiloride—Decreased appetite—Temozolomide—brain cancer	0.000903	0.00321	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CCND1—brain cancer	0.000899	0.00311	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Temozolomide—brain cancer	0.000896	0.00319	CcSEcCtD
Amiloride—Fatigue—Temozolomide—brain cancer	0.000895	0.00319	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CTNNB1—brain cancer	0.00089	0.00308	CbGpPWpGaD
Amiloride—Cough—Etoposide—brain cancer	0.000888	0.00316	CcSEcCtD
Amiloride—Pain—Temozolomide—brain cancer	0.000888	0.00316	CcSEcCtD
Amiloride—Constipation—Temozolomide—brain cancer	0.000888	0.00316	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—STAT3—brain cancer	0.000886	0.00307	CbGpPWpGaD
Amiloride—Feeling abnormal—Carmustine—brain cancer	0.000885	0.00315	CcSEcCtD
Amiloride—Dizziness—Hydroxyurea—brain cancer	0.000879	0.00313	CcSEcCtD
Amiloride—Gastrointestinal pain—Carmustine—brain cancer	0.000879	0.00313	CcSEcCtD
Amiloride—Chest pain—Etoposide—brain cancer	0.000867	0.00309	CcSEcCtD
Amiloride—Feeling abnormal—Temozolomide—brain cancer	0.000856	0.00305	CcSEcCtD
Amiloride—Abdominal pain—Carmustine—brain cancer	0.000849	0.00302	CcSEcCtD
Amiloride—Gastrointestinal pain—Temozolomide—brain cancer	0.000849	0.00302	CcSEcCtD
Amiloride—Vomiting—Hydroxyurea—brain cancer	0.000845	0.00301	CcSEcCtD
Amiloride—SLC9A1—Disease—HES5—brain cancer	0.000844	0.00292	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TP53—brain cancer	0.000844	0.00292	CbGpPWpGaD
Amiloride—Rash—Hydroxyurea—brain cancer	0.000838	0.00298	CcSEcCtD
Amiloride—Confusional state—Etoposide—brain cancer	0.000838	0.00298	CcSEcCtD
Amiloride—Dermatitis—Hydroxyurea—brain cancer	0.000837	0.00298	CcSEcCtD
Amiloride—Headache—Hydroxyurea—brain cancer	0.000833	0.00297	CcSEcCtD
Amiloride—Abdominal pain—Temozolomide—brain cancer	0.000821	0.00292	CcSEcCtD
Amiloride—PLAU—Hemostasis—TRPC6—brain cancer	0.000806	0.00279	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—EGFR—brain cancer	0.000805	0.00279	CbGpPWpGaD
Amiloride—Anorexia—Etoposide—brain cancer	0.000792	0.00282	CcSEcCtD
Amiloride—Nausea—Hydroxyurea—brain cancer	0.000789	0.00281	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000774	0.00268	CbGpPWpGaD
Amiloride—Asthenia—Carmustine—brain cancer	0.000771	0.00275	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000767	0.00265	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—MYC—brain cancer	0.00076	0.00263	CbGpPWpGaD
Amiloride—Paraesthesia—Etoposide—brain cancer	0.000746	0.00266	CcSEcCtD
Amiloride—Asthenia—Temozolomide—brain cancer	0.000745	0.00265	CcSEcCtD
Amiloride—Dyspnoea—Etoposide—brain cancer	0.000741	0.00264	CcSEcCtD
Amiloride—Somnolence—Etoposide—brain cancer	0.000739	0.00263	CcSEcCtD
Amiloride—Diarrhoea—Carmustine—brain cancer	0.000735	0.00262	CcSEcCtD
Amiloride—Pruritus—Temozolomide—brain cancer	0.000735	0.00262	CcSEcCtD
Amiloride—Decreased appetite—Etoposide—brain cancer	0.000722	0.00257	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MYC—brain cancer	0.000721	0.00249	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Etoposide—brain cancer	0.000717	0.00255	CcSEcCtD
Amiloride—Fatigue—Etoposide—brain cancer	0.000716	0.00255	CcSEcCtD
Amiloride—Dizziness—Carmustine—brain cancer	0.00071	0.00253	CcSEcCtD
Amiloride—Constipation—Etoposide—brain cancer	0.00071	0.00253	CcSEcCtD
Amiloride—Pain—Etoposide—brain cancer	0.00071	0.00253	CcSEcCtD
Amiloride—Diarrhoea—Temozolomide—brain cancer	0.00071	0.00253	CcSEcCtD
Amiloride—Dizziness—Temozolomide—brain cancer	0.000687	0.00245	CcSEcCtD
Amiloride—Feeling abnormal—Etoposide—brain cancer	0.000685	0.00244	CcSEcCtD
Amiloride—Vomiting—Carmustine—brain cancer	0.000683	0.00243	CcSEcCtD
Amiloride—Gastrointestinal pain—Etoposide—brain cancer	0.000679	0.00242	CcSEcCtD
Amiloride—Rash—Carmustine—brain cancer	0.000677	0.00241	CcSEcCtD
Amiloride—Dermatitis—Carmustine—brain cancer	0.000677	0.00241	CcSEcCtD
Amiloride—Headache—Carmustine—brain cancer	0.000673	0.0024	CcSEcCtD
Amiloride—Vomiting—Temozolomide—brain cancer	0.00066	0.00235	CcSEcCtD
Amiloride—Abdominal pain—Etoposide—brain cancer	0.000657	0.00234	CcSEcCtD
Amiloride—Rash—Temozolomide—brain cancer	0.000655	0.00233	CcSEcCtD
Amiloride—Dermatitis—Temozolomide—brain cancer	0.000654	0.00233	CcSEcCtD
Amiloride—Headache—Temozolomide—brain cancer	0.00065	0.00232	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CYP2C9—brain cancer	0.00065	0.00225	CbGpPWpGaD
Amiloride—Nausea—Carmustine—brain cancer	0.000638	0.00227	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—brain cancer	0.000624	0.00216	CbGpPWpGaD
Amiloride—Nausea—Temozolomide—brain cancer	0.000617	0.0022	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—brain cancer	0.00061	0.00211	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	0.000609	0.00211	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VAV1—brain cancer	0.000604	0.00209	CbGpPWpGaD
Amiloride—Asthenia—Etoposide—brain cancer	0.000596	0.00212	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—brain cancer	0.000592	0.00205	CbGpPWpGaD
Amiloride—Pruritus—Etoposide—brain cancer	0.000588	0.00209	CcSEcCtD
Amiloride—Diarrhoea—Etoposide—brain cancer	0.000568	0.00202	CcSEcCtD
Amiloride—SLC9A1—Disease—IDH1—brain cancer	0.000568	0.00196	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—BSG—brain cancer	0.000553	0.00191	CbGpPWpGaD
Amiloride—Dizziness—Etoposide—brain cancer	0.000549	0.00196	CcSEcCtD
Amiloride—SLC9A1—Disease—HEY1—brain cancer	0.000538	0.00186	CbGpPWpGaD
Amiloride—Vomiting—Etoposide—brain cancer	0.000528	0.00188	CcSEcCtD
Amiloride—SLC9A1—Disease—DLL1—brain cancer	0.000528	0.00183	CbGpPWpGaD
Amiloride—Rash—Etoposide—brain cancer	0.000524	0.00187	CcSEcCtD
Amiloride—Dermatitis—Etoposide—brain cancer	0.000523	0.00186	CcSEcCtD
Amiloride—Headache—Etoposide—brain cancer	0.00052	0.00185	CcSEcCtD
Amiloride—Nausea—Etoposide—brain cancer	0.000494	0.00176	CcSEcCtD
Amiloride—SLC9A1—Metabolism—IDH1—brain cancer	0.000475	0.00164	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SHH—brain cancer	0.000449	0.00155	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ENO2—brain cancer	0.000449	0.00155	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CG—brain cancer	0.000384	0.00133	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ENO2—brain cancer	0.000376	0.0013	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000363	0.00125	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000354	0.00122	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000338	0.00117	CbGpPWpGaD
Amiloride—SLC9A1—Disease—VAV1—brain cancer	0.000324	0.00112	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HES1—brain cancer	0.000279	0.000965	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IL2—brain cancer	0.00027	0.000934	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PDGFRA—brain cancer	0.000265	0.000919	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IRS2—brain cancer	0.000233	0.000806	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—brain cancer	0.000229	0.000794	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APC—brain cancer	0.000206	0.000712	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—brain cancer	0.000173	0.0006	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CG—brain cancer	0.000172	0.000596	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000167	0.000579	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—brain cancer	0.00016	0.000553	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000156	0.00054	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2C9—brain cancer	0.000141	0.000487	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CTNNB1—brain cancer	0.00014	0.000484	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2C9—brain cancer	0.000131	0.000454	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—brain cancer	0.000122	0.000422	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BSG—brain cancer	0.00012	0.000414	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—brain cancer	0.000113	0.000392	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BSG—brain cancer	0.000112	0.000386	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—brain cancer	0.000111	0.000383	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—IDH1—brain cancer	0.000103	0.000356	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—IDH1—brain cancer	9.59e-05	0.000332	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ENO2—brain cancer	8.13e-05	0.000281	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ENO2—brain cancer	7.58e-05	0.000262	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CG—brain cancer	3.73e-05	0.000129	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CG—brain cancer	3.48e-05	0.00012	CbGpPWpGaD
